Pixium Vision (ALPIX.PA) Stock Price

Pixium Vision Price

CLOSED
0
​
Market closed

Revenue at Pixium Vision has contracted by 7.2% per year over the past 7 years to 1.96 M EUR. For Pixium Vision, the net margin of -527.5% is up versus -830.6% a few years ago.

Pixium Vision stock price

Access this data via the Eulerpool API

Pixium Vision business model & stock analysis

Pixium Vision SA conducts research and development on retinal implants. The company is headquartered in Paris, Ile-De-France and currently employs 29 full-time employees. The company went IPO on 2014-06-19. The firm is focused on the development of implantable medical devices for the treatment of blindness caused by degeneration of photoreceptor cells in the retina. The firm develops two Vision Restoration Systems (VRS) platforms, including IRIS and PRIMA. The Company’s implant technology replaces the signal processing functions in the retina by electrically stimulating the retinal cells, enabling them to transmit the stimulation signals to the brain’s visual cortex via the optic nerve, and its other systems initially enables patients with retinitis pigmentosa to partially recover their vision. The firm has collaboration with technology and academic institutions, including the Institut de la Vision (Paris), Universite Pierre et Marie Curie (Paris), Stanford University (the United States) and University of Ulm (Germany).

Frequently asked questions about Pixium Vision

9 analysts currently rate the Pixium Vision stock: 8 recommend buying, 1 holding and 0 selling.

The revenue cannot currently be calculated for Pixium Vision.

The profit cannot currently be calculated for Pixium Vision.

The P/E ratio cannot be calculated for Pixium Vision at the moment.

The P/S cannot be calculated for Pixium Vision currently.

The Eulerpool Quality Score for Pixium Vision is 2/10.

The ISIN of Pixium Vision is FR001400JX97. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Pixium Vision is A116CC. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Pixium Vision is ALPIX.PA. The ticker symbol is used to trade Pixium Vision shares on the stock exchange.

Fair ValueTerminal
148.30 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
67,413.79 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
EUR
Initial public offering
Jun 19, 2014
ISIN
FR001400JX97
Cusip
F7S336106
Sedol
BMSJTW7
Market capitalization
1.53 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2023
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-125.31 %
Last updated Oct 9, 2026, 7:45 PM

All fundamentals and in-depth analysis of Pixium Vision

Our stock analysis for Pixium Vision stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pixium Vision. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.